Sign Up
OverviewAPI
The global small molecule drug discovery market is projected to reach significant values, with expected growth driven by factors such as the rising incidence of chronic diseases, technological innovations, and government support for pharmaceutical firms. Key events include major acquisitions and product launches by companies like GSK Plc. and Dotmatics. The market is also segmented by various aspects, including drug type, technology, therapeutic area, process/phase, end-user, region, and country.

Ask a question